Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
- Merck: 2 events in the last 90 days
- Previous: 64 days earlier · Moderna and Merck shares soar on mRNA cancer vaccine
What happened
Markers released top-line results today after previously reporting the trial succeeded.
Summary assembled by rule from the sources below